Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Beiderwellen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2014
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncologyPhilipp Heusch, Felix Nensa, Benedikt Schaarschmidt, et al.
European Journal of Radiology|December 29, 2016
Contrast enhanced renal MR angiography at 7 Tesla: How much gadolinium do we need?Karsten Beiderwellen, Oliver Kraff, Anja Laader, et al.
Plos One|May 9, 2014
Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancerJohannes Grueneisen, Karsten Beiderwellen, Philipp Heusch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2014
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial resultsKarsten Beiderwellen, Johannes Grueneisen, Verena Ruhlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2016
68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum ThyroglobulinIna Binse, Thorsten D Poeppel, Marcus Ruhlmann, et al.
European Journal of Radiology|February 23, 2013
Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?Christian Buchbender, Verena Hartung-Knemeyer, Karsten Beiderwellen, et al.
European Journal of Radiology|May 16, 2015
Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR readingBenedikt M Schaarschmidt, Johannes Grueneisen, Philipp Heusch, et al.
Plos One|July 7, 2017
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumineJulian Kirchner, Lino M Sawicki, Cornelius Deuschl, et al.
Investigative Radiology|March 7, 2013
Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial resultsAxel Wetter, Christine Lipponer, Felix Nensa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Diagnostic value of diffusion-weighted imaging in simultaneous 18F-FDG PET/MR imaging for whole-body staging of women with pelvic malignanciesJohannes Grueneisen, Benedikt Michael Schaarschmidt, Karsten Beiderwellen, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2014
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncologyPhilipp Heusch, Felix Nensa, Benedikt Schaarschmidt, et al.
European Journal of Radiology|December 29, 2016
Contrast enhanced renal MR angiography at 7 Tesla: How much gadolinium do we need?Karsten Beiderwellen, Oliver Kraff, Anja Laader, et al.
Plos One|May 9, 2014
Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancerJohannes Grueneisen, Karsten Beiderwellen, Philipp Heusch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2014
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial resultsKarsten Beiderwellen, Johannes Grueneisen, Verena Ruhlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2016
68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum ThyroglobulinIna Binse, Thorsten D Poeppel, Marcus Ruhlmann, et al.
European Journal of Radiology|February 23, 2013
Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?Christian Buchbender, Verena Hartung-Knemeyer, Karsten Beiderwellen, et al.
European Journal of Radiology|May 16, 2015
Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR readingBenedikt M Schaarschmidt, Johannes Grueneisen, Philipp Heusch, et al.
Plos One|July 7, 2017
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumineJulian Kirchner, Lino M Sawicki, Cornelius Deuschl, et al.
Investigative Radiology|March 7, 2013
Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial resultsAxel Wetter, Christine Lipponer, Felix Nensa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Diagnostic value of diffusion-weighted imaging in simultaneous 18F-FDG PET/MR imaging for whole-body staging of women with pelvic malignanciesJohannes Grueneisen, Benedikt Michael Schaarschmidt, Karsten Beiderwellen, et al.
Pageof 3